<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01123421</url>
  </required_header>
  <id_info>
    <org_study_id>BUSS03</org_study_id>
    <secondary_id>2R44AG017400</secondary_id>
    <nct_id>NCT01123421</nct_id>
  </id_info>
  <brief_title>Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment</brief_title>
  <acronym>BUSS03</acronym>
  <official_title>Portable Ultrasonometer for Osteoporosis Assessment: Retrospective Fracture Risk Validation Study, Version #1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Artann Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Artann Laboratories</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to demonstrate that the Bone UltraSonic Scanner (BUSS) can aid in detection of
      osteoporosis and predict prevalent osteoporotic fractures. Measurements derived from the BUSS
      parameters will be able to discriminate between postmenopausal women with osteoporotic
      fractures when compared to matched controls without history of osteoporotic fracture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of several studies to develop and clinically validate a novel ultrasonographic device,
      BUSS, for the assessment of osteoporosis and fracture risk.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine whether BUSS testing is equivalent or superior to DXA for fracture risk assessment in postmenopausal women.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">113</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Fracture</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>With osteoporotic fracture</arm_group_label>
    <description>Approximately 100 postmenopausal women that have been enrolled in a population-based case-control study that have experienced a clinically-diagnosed fracture of thoracolumbar spine or distal forearm due to minimal or moderate trauma based on review on their inpatient and outpatient medical records will be enrolled.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without osteoporotic fracture</arm_group_label>
    <description>Approximately 100 control women will have no history of a prior spine, hip, or wrist fracture.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Both groups
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  postmenopausal women with osteoporotic fracture at spine or wrist

          -  postmenopausal women no history of fracture at spine or wrist

        Exclusion Criteria:

          -  women with a history of metabolic disease

          -  stroke

          -  tibia fracture or surgery

          -  BMI â‰¥ 35 kg/m2

          -  Teriparatide use currently or within the past 6 months,

          -  Any skin issues (open wounds or rashes, and/or skin infections) of the tibial area.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Armen Sarvazyan, Ph.D., D.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Artann Laboratories, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2010</study_first_submitted>
  <study_first_submitted_qc>May 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2010</study_first_posted>
  <last_update_submitted>October 11, 2012</last_update_submitted>
  <last_update_submitted_qc>October 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoporosis</keyword>
  <keyword>fracture risk</keyword>
  <keyword>aging</keyword>
  <keyword>tibia</keyword>
  <keyword>sonometer</keyword>
  <keyword>ultrasound</keyword>
  <keyword>BMD</keyword>
  <keyword>bone mineral density</keyword>
  <keyword>DXA</keyword>
  <keyword>3D-HRpQT</keyword>
  <keyword>waveform profiles</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Osteoporotic Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

